MetaCap

Allogene Therapeutics (ALLO) News

NASDAQ: ALLOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.6277-0.0392 (-5.88%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ALLO news summary

We found 6 recent headlines mentioning Allogene Therapeutics (ALLO): 1 in the past week and 6 in the past 30 days, most often from GlobeNewswire. ALLO is making an outsized move today, down 5.88% at $0.6277, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Allogene Therapeutics to Host Events at American Society of Hematology Annual Meeting 2026 Highlighting the Potential of Allogeneic CAR T to Expand Patient Access", was published by GlobeNewswire on Nov 20, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Allogene Therapeutics headlines

Compare ALLO